Cymab ApS is a Danish APS based in København N, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2018, the company has 2 employees and reported a gross profit of -DKK 5.5m in its latest annual filing.
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed indenfor forskning, udvikling og markedsføring af farmaceutiske og medicinske præparater samt anden efter bestyrelsens skøn beslægtet virksomhed.
In its most recent annual report (2025), Cymab ApS reported a gross profit of -DKK 5.5m. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 7.6m.
At the end of 2025, current assets covered short-term debt 2.2 times.
Frequently asked questions
What is the CVR number of Cymab ApS?
Cymab ApS is registered with CVR / Virk under CVR 39859173.
What is the gross profit of Cymab ApS?
Cymab ApS reported a gross profit of -DKK 5.5m in 2025.
How many employees does Cymab ApS have?
Cymab ApS employs 2 people as of the latest annual report.
Who is the CEO of Cymab ApS?
Johan Henrik Faber is the CEO of Cymab ApS, in role since 2023.
Who is the chairman of Cymab ApS?
Hans Heugh Wandall chairs the board of Cymab ApS, in role since 2023.
Where is Cymab ApS headquartered?
Cymab ApS's registered address is Ole Maaløes Vej 3.
